BSX’s Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of gastrointestinal (GI) and pulmonary treatment options.
Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one’s portfolio. Wall Street analysts’ overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Boston Scientific’s new buyout is set to expand its interventional oncology offerings.
Boston Scientific (BSX) reported earnings 30 days ago. What’s next for the stock? We take a look at earnings estimates for some clues.
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Anheuser-Busch, Constellation, Molson Coors, Boston Beer and Duckhorn have been highlighted in this Industry Outlook article.
Federal Reserve Bank of Boston President Susan Collins said on Wednesday that more interest-rate cuts are needed, but policymakers should proceed carefully to avoid moving too quickly or too slowly, per Bloomberg.
Whether you’re a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors remain optimistic about Boston Scientific due to its geographical expansions and impressive acquisitions.
Boston Scientific announces favorable OPTION trial results for its WATCHMAN FLX LAAC device. In terms of stroke risk reduction, WATCHMAN FLX is found to be superior to OAC therapy.
BSX’s acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.
Federal Reserve (Fed) Bank of Boston President Susan Collins hit the wires on Friday, downplaying pressures for continued rate cuts in the near term, but also keeping a steady hand underneath market expectations of a rate trim in December.
The exhibition collects more than 125 films in monumental and immersive multichannel installations the artist describes as “walk-through experiences.”
Whether you’re a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Progressive, Qualcomm, GE Aerospace, S&P Global and Boston Scientific are included in this Analyst Blog.
Boston Scientific (BSX) possesses solid growth attributes, which could help it handily outperform the market.
mazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction are part of the Zacks top Analyst Blog.
Needham & Company LLC reaffirmed a “hold” rating on shares of Boston Scientific in a research report on Thursday.
Today’s Research Daily features new research reports on 12 major stocks, including Amazon.com, Inc. (AMZN), Johnson & Johnson (JNJ) and Boston Scientific Corporation (BSX), as well as a micro-cap stock Armanino Foods of Distinction, Inc. (AMNF).
HAE vs. BSX: Which Stock Is the Better Value Option?
BXP’s Q3 FFO per share matches estimates. Results reflect higher revenues amid healthy leasing activity. However, high interest expenses hurt.
The headline numbers for Boston Properties (BXP) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Papantoniadis forced or attempted to force six victims — five men and one woman — to work for him and comply with excessive workplace demands.
Wealth Enhancement Advisory Services LLC increased its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 123.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. T…
The owner of two Boston-area pizza shops convicted of forced labor for using physical violence and threats of reprisal or deportation against employees living in the country illegally has been sentenced to more than eight years in prison
First American Bank lessened its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 5.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 128,834 shares of the medica…
Boston Trust Walden Corp lessened its position in Comfort Systems USA, Inc. (NYSE:FIX – Free Report) by 99.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owne…
Boston Trust Walden Corp lowered its stake in Dollar General Co. (NYSE:DG – Free Report) by 61.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 35,483 shares of the company’s stock after selling 55…
Boston Trust Walden Corp raised its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 1,417.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,…
Boston Trust Walden Corp boosted its position in American Water Works Company, Inc. (NYSE:AWK – Free Report) by 258.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission….
Boston Trust Walden Corp trimmed its holdings in NetApp, Inc. (NASDAQ:NTAP – Free Report) by 87.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 61,770 shares of the data stor…
Boston Trust Walden Corp lessened its stake in Core Laboratories Inc. (NYSE:CLB – Free Report) by 17.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 600,833 shares of the oil…
Boston Trust Walden Corp decreased its position in Schlumberger Limited (NYSE:SLB – Free Report) by 8.0% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 355,019 shares of the oil and gas comp…
Boston Trust Walden Corp increased its stake in shares of Atkore Inc. (NYSE:ATKR – Free Report) by 9.0% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 188,355 shares of the company’s stoc…
Boston Trust Walden Corp reduced its stake in shares of Cable One, Inc. (NYSE:CABO – Free Report) by 5.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional…
Boston Trust Walden Corp cut its position in InMode Ltd. (NASDAQ:INMD – Free Report) by 2.4% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,408,071 shares of t…
Boston Trust Walden Corp lowered its stake in Unitil Co. (NYSE:UTL – Free Report) by 2.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3…
Boston Trust Walden Corp bought a new position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor b…
Boston Trust Walden Corp trimmed its position in 1st Source Co. (NASDAQ:SRCE – Free Report) by 2.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 425,318 shares…
Boston Trust Walden Corp decreased its stake in shares of UMB Financial Co. (NASDAQ:UMBF – Free Report) by 12.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor …
Boston Trust Walden Corp grew its stake in shares of Lululemon Athletica Inc. (NASDAQ:LULU – Free Report) by 360.0% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 131,276 shares of the a…
Boston Trust Walden Corp trimmed its position in shares of Installed Building Products, Inc. (NYSE:IBP – Free Report) by 2.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. …
Boston Trust Walden Corp trimmed its position in Independent Bank Corp. (NASDAQ:INDB – Free Report) by 2.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 619,313 sha…
The Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live qoute and chart technical analysis, opinion, price forecast on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.